Leaflet INFRES 2mg / ml syrup


Indicated for: respiratory inflammation; bronchial symptoms

Route of administration: oral

Substance: fenspiride (anti-inflammatory agent)

ATC: R03DX03 (Respiratory system | Other systemic drugs for obstructive airway diseases)

Fenspiride is a medication used to treat respiratory conditions such as bronchitis, rhinopharyngitis, and other acute or chronic respiratory diseases. It works by reducing inflammation and mucus hypersecretion, with anti-inflammatory, antiallergic, and bronchodilatory properties.

It is indicated for relieving respiratory symptoms such as cough and breathing difficulties and is available in tablet or syrup form. The dosage and duration of treatment are determined by the doctor based on the patient’s age and condition.

Common side effects include nausea, vomiting, abdominal pain, and drowsiness. Rarely, severe allergic reactions or cardiac issues, such as QT interval prolongation, may occur.

Fenspiride should be used as directed by a doctor. In some countries, its use has been restricted due to the risk of cardiac side effects.

General data about INFRES 2mg / ml

  • Substance: fenspiride
  • Date of last drug list: 01-10-2015
  • Commercial code: W61869001
  • Concentration: 2mg / ml
  • Pharmaceutical form: syrup
  • Quantity: 1
  • Product type: generic
  • Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Pharmaceutical forms available for fenspiride

Concentrations available for fenspiride

  • 2mg/ml
  • 80mg